Free Trial

John Young Analyst Performance

Analyst at Canaccord Genuity Group

John Young is a stock analyst at Canaccord Genuity Group in the medical sector, covering 3 publicly traded companies. Over the past year, John Young has issued 6 stock ratings, including buy and hold recommendations. While full access to John Young's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights John Young's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
6 Last 0 Years
Buy Recommendations
66.67% 4 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%4 ratings
Hold33.3%2 ratings
Sell0.0%0 ratings

Out of 6 total stock ratings issued by John Young at Canaccord Genuity Group, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
3 companies

John Young, an analyst at Canaccord Genuity Group, currently covers 3 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies
100.0%

John Young of Canaccord Genuity Group specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED/DENTAL - SUPP
2 companies
66.7%
MED INSTRUMENTS
1 company
33.3%

John Young's Ratings History at Canaccord Genuity Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
STAAR Surgical Company stock logo
STAA
STAAR Surgical
4/9/2026Upgrade$20.88$27.00Buy
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
4/6/2026Lower Price Target$9.87$16.00Buy
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1/15/2026Lower Price Target$21.01$22.00Hold
STAAR Surgical Company stock logo
STAA
STAAR Surgical
12/9/2025Boost Price Target$25.91$30.75Hold
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
10/16/2025Boost Price Target$80.47$104.00Buy
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
10/3/2025Boost Price Target$11.86$18.00Buy